MUMBAI, India, Nov. 2 -- Intellectual Property India has published a patent application (202611110892 A) filed by Noida Institute Of Engineering And Technology Pharmacy Institute on September 16, 2026, for Stearic Acid-Based Nanoemulsion Formulation For Enhanced Therapeutic Delivery Of Talazoparib For Treatment Of Breast Cancer.
Inventors include Neha Sharma; and Nidhi Sharma.
The application for the patent was published on October 30, 2026, under issue no. 44/2026.
Abstract: The present invention relates to a stearic acid-based nanoemulsion formulation comprising talazoparib, a potent PARP inhibitor, encapsulated within a lipid matrix of distearoyl phosphatidylcholine, stearic acid, and Tween-80, prepared by solvent injection followed b...